Pharmacists in community-based practice.
Universal program number: 0401-0000-13-011-H01-P
Activity type: Knowledge-based
To improve the pharmacist’s ability to address medication therapy issues related to male specific disease states, including benign prostatic hyperplasia, erectile dysfunction, hypogonadism and prostate cancer.
Confusion about men’s health issues could be compounded when coupled with new medications that have been approved by the Food and Drug Administration, or FDA, over the past year and uncertainties among prescribers regarding the therapeutic use and adverse events of already well-established medications. Thus, it is incumbent upon pharmacists to be aware of men’s health issues and associated medications and to be able to counsel accordingly.
Upon completion of this program, the pharmacist should be able to:
- Compare and contrast new medications with traditional therapy options for men’s health-related diseases states, including benign prostatic hyperplasia, erectile dysfunction, testosterone replacement therapy and prostate cancer.
- Analyze therapy and counseling needed for men in the community setting with erectile dysfunction or hypogonadism.
- Explain screening recommendations for prostate cancer prevention and provide appropriate counseling to men in the community setting.
- Construct a care plan for men with benign prostatic hyperplasia, addressing concerns with implementing therapy, adverse events and counseling.
To obtain credit:
A minimum test score of 70% is needed to obtain credit. Submit your answers to the learning assessment questions online at DrugStoreNewsCE.com. Your statement of credit will be available through CPE Monitor located at NABP.net. To ensure transmission of credit hours to CPE Monitor, you must enter your correct e-PID number in your CE profile.
All customer service questions should be directed to (800) 933-9666.
If you are a paid enrollee, there is no cost to participate in this lesson. The fee for participants who are not enrolled is $13.95.
Drug Store News is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This CPE Activity is approved for pharmacists and is worth 2.0 contact hours (0.2 CEUs). The activity is available for CE credit through September 25, 2016.